抗菌水凝胶敷料的制备及性能

以乙二醇二缩水甘油醚(GDE)为偶联剂,将胍盐低聚物(PHMG)接枝到淀粉上,形成淀粉接枝物(Starch-g-PHMG)。然后,将一定比例的Starch-g-PHMG与淀粉-丙烯酸接枝共聚物共混,制备了抗菌水凝胶敷料(AHD)。通过红外光谱(FT-IR)、元素分析确定了Starch-g-PHMG的分子结构;通过吸液测试、抗菌测试表征了AHD的理化性能。结果表明:在反应温度为60°C,反应时间为3h,w(NaOH)=0.4%时,Starch-g-PHMG中PHMG的接枝效率最高,可达37.5%;AHD的吸液率随着Starch-g-PHMG含量的增加而减少;当w(PHMG)0.33%时,AHD对金黄色葡萄球菌与大肠杆菌的抑菌率可以达到100%。     

可注射水凝胶的制备与应用

可注射水凝胶在再生医学和药物控释等方面有着广泛的用途,是近年来生物医用材料领域新的研究方向.本文综述了近年来人们在可注射水凝胶制备和应用方面的研究进展,最后展望了其发展前景.     

可注射的壳聚糖水凝胶的制备及应用进展

可注射的水凝胶由于其独特的性质在生物医学领域中备受关注。壳聚糖是自然界中唯一的一种阳离子多糖,具有含量丰富、价格低廉、生物相容性和生物可降解性良好等优点,经常被用来制备可注射的水凝胶。近年来,随着研究的进一步深入,通过采用各种化学或物理改性和修饰方法、引入各种生物功能分子或采用各种交联方法,具有优异性能的可注射的壳聚糖水凝胶不断涌现,其应用范围不断扩展,在实际应用中发挥了越来越重要的作用。本文主要介绍了常见的化学交联的和物理交联的可注射的壳聚糖水凝胶的制备方法,综述了其在药物载体、基因载体、细胞支架和伤口修复等生物医学领域中的应用进展,对其存在的问题及发展趋势进行了分析和展望,为可注射的壳聚糖水凝胶的进一步发展提供指导和借鉴。     

壳聚糖基可注射型温度敏感性水凝胶

壳聚糖基可注射型温度敏感性水凝胶是一种pH值中性的,在室温或低于室温时可保持液态,温度达到体温时可凝胶化的材料,有望被广泛应用于药物释放和组织工程领域,作为多肽和蛋白质等生物活性药物的可注射型释放载体或组织修复材料.本文介绍了壳聚糖基可注射型温敏性水凝胶的种类、特性、机制和应用等方面的研究进展.     

硫酸软骨素类可注射水凝胶体系及其凝胶化机制

硫酸软骨素是一种硫酸化糖胺聚糖类天然多糖,广泛分布于动物组织的细胞外基质和细胞表面,具有促进软骨生长、调控生长因子、加快伤口愈合等多种生物功能.近年来,基于硫酸软骨素良好的生物活性、生物相容性和生物降解性,硫酸软骨素类可注射水凝胶作为一种新型生物材料受到了广泛关注,尤其是在组织工程、药物输送和细胞治疗等生物医用领域的应...     

通过麦克加成反应形成的三臂聚乙二醇丙烯酸酯可注射水凝胶的制备与表征

通过麦克加成反应在磷酸盐缓冲溶液中制备出一种基于三臂聚乙二醇丙烯酸酯的能快速固化的可注射水凝胶.采用倒置法测定了体系的凝胶化时间.通过红外,DMA,溶胀,降解等一系列测试,研究了该水凝胶的结构和物理化学性能.观察到通过控制前体溶液的浓度,可以控制凝胶的成胶时间和所形成凝胶的溶涨率.同时表明该水凝胶具备可注射性和可降解性.细胞毒性评价显示,该水凝胶浸提液无毒性,符合生物材料的安全评价标准.由于麦克加成反应可在人体生理条件(pH7.4,37℃)下快速进行,并且不需要任何引发剂、催化剂和有机溶剂,因此该反应非常适合应用于生物医用材料领域.     

可注射水凝胶及其在再生医学领域的应用

近年来,由工程生物材料制成的可注射治疗剂正变得越来越流行,并推动传统的临床实践走向微创化.可注射水凝胶由于其可调控的物理及化学特性、可控的降解性能、高含水量以及在微创方式下实现递送的能力,在组织工程和药物递送领域中变得越来越重要.研究者们已开发出例如原位交联水凝胶、大孔水凝胶、水凝胶微粒、动态交联水凝胶等一系列性能独特的可注射水凝胶.通过调控水凝胶的固含量和交联密度,并引入适当的共价或非共价相互作用,例如静电相互作用、疏水相互作用等,这些水凝胶可在注射过程中实现生物活性分子的递送.同时,可注射水凝胶亦可用于细胞的递送,提供细胞培养所需的三维环境,并通过调控力学性能、化学修饰、生物功能化修饰等手段调控细胞黏附、增殖、分化等行为.本文旨在回顾近年来可注射水凝胶的设计和制备的相关进展,以及其在再生医学中的应用,并对该领域存在的挑战和潜力进行了展望.     

聚L-谷氨酸可注射水凝胶的制备及性能

通过活化改性聚L-谷氨酸（PLGA）制备酰肼化PLGA（PLGA-ADH）和3-氨基-1,2-丙二醇改性的PLGA（PLGA-OH）,PLGA-OH经高碘酸钠氧化制得醛基化PLGA（PLGA-CHO）,以PLGA-ADH和PLGA-CHO为前驱体,通过席夫碱交联反应构建了PLGA可注射水凝胶.研究了酰肼化和醛基化改性前后PLGA的结构变化,考察了固含量对水凝胶成胶时间、溶胀行为、机械性能、体外降解性能、药物释放行为及微观形貌等的影响,并进行了初步的细胞培养实验及裸鼠皮下注射成胶实验.结果表明,该PLGA可注射水凝胶在组织工程领域具有良好的应用前景.     

ε－聚赖氨酸增强的可注射白蛋白水凝胶

牛血清白蛋白水凝胶拥有优异的生物相容性及生物降解性,被广泛应用于组织工程领域中.目前已经成功制备了可注射牛血清白蛋白水凝胶,但其力学性能仍有待提高.本文利用一种简单的方法提高了该可注射白蛋白水凝胶的力学性能.以尿素为变性剂,谷胱甘肽为还原剂制备由氢键及二硫键协同作用的白蛋白凝胶网络,并在牛血清白蛋白完全解旋后在体系中物...     

外敷用高分子材料研究进展

皮肤受损后需要立即使用外敷材料,从而加速止血、保护创面、防止细菌感染,并促进创面愈合。本文在介绍伤口的分类和敷料的选择的基础上,就典型的敷料制备、干燥和成型技术,以及目前常见的外敷材料药物负载方法进行了概述。其次,重点阐述了天然高分子和合成高分子外敷材料的最新研究进展。其中天然高分子因其生物相容性好、生物可降解等特点,常用于治疗烧伤、创伤引起的皮肤和组织缺损。而合成高分子优点为:具有很长的保质期、较强的机械性能和较低的炎症反应,几乎没有携带病菌并传播的风险。目前,改性天然高分子、合成高分子及其复合材料已经在生物医药、材料学领域受到越来越多的关注。纳米技术和药物控释技术的发展,将会大大推动外敷材料的研究开发并拓宽其应用领域。     

天然高分子外敷材料研究进展

外敷材料能在皮肤受损后起到保护创面、控制感染、促进愈合的作用。本文首先介绍了外敷材料的选择依据与分类。然后,从结构特点与应用角度出发,阐述了天然高分子外敷材料的最新研究进展。可用作外敷材料的多糖包括纤维素、海藻酸盐、甲壳素与壳聚糖、琼脂糖、果胶与树胶、糖胺聚糖等;蛋白类外敷材料分为植物蛋白和动物蛋白外敷材料。随着高分子合成技术和药物控释技术的发展,将会大大推动外敷材料的研究开发,并拓宽其应用领域。     

Strong and Injectable Hydrogels Based on Multivalent Metal Ion-Peptide Cross-linking

Injectable hydrogels are ideal biomaterials for delivering cells, growth factors and drugs specifically to localized lesions and subsequent controlled release. Many factors can affect the efficacy of injectable hydrogels. To avoid potential damage to encapsulated cells or drugs, injectable hydrogels should be highly dynamic so that they can undergo shear-thinning at low strain rates and rapidly reform after injection. However, dynamic hydrogels are often mechanically weak, leading to the leakage of encapsulated cells or drugs. Here we demonstrated a convenient method to improve the mechanical strength without jeopardizing the dynamic properties of hydrogels by using metal ion-peptide crosslinkers containing multiple metal ion-ligand bonds. We showed that the dynamic properties of the hydrogels correlated with the intrinsic dynamics of the metal-ligand bonds and were not affected by the formation of multivalent binding. Yet, the mechanical stability of the hydrogels was significantly improved due to the increased thermodynamic stability of the crosslinkers. We further showed that the drug release rates were slowed down by the formation of multivalent crosslinkers. Our results highlight the importance of ligand valency to the mechanical response of hydrogels and provide a universal route to rationally tune the dynamic and mechanical properties of injectable hydrogels.     

Current Intelligent Injectable Hydrogels for In Situ Articular Cartilage Regeneration

Abstract

A high number of sport injuries result in damage to articular cartilage, a tissue type with poor self-healing capacity. Articular cartilage tissue is a sophisticated hydrogel, which contains 80% water and possesses strong mechanical properties. For this reason, synthetic hydrogels are thought to be an optimal material for cartilage regeneration. In the last decade, more than 2,000 research papers pertaining to “hydrogel and cartilage” have been published. Due to its biomimetic properties and user-friendly nature, especially in the field of minimal invasive surgery, intelligent injectable hydrogel have gradually become a focal point in cartilage research in recent years. In this review, we systematically summarize current “state-of-the-art” manufacture technologies of injectable hydrogels including ion-induced, thermo-induced, non-induced chemical, and light-induced crosslinking. We also review current strategies for designing intelligent injectable hydrogels, such as component-based, mechanical property-based and structure-based intelligent design to simulate the natural articular cartilage. Lastly, the applications of intelligent injectable hydrogels for cartilage regeneration are presented, and their outlooks for future clinical translation is dicussed.     

壳聚糖基抗菌型创伤敷料的研究进展

近年来,随着再生医学的快速发展,组织工程技术再造人体组织器官被广泛的关注和研究。其中对加速创伤修复的敷料材料设计非常重要,其结构性质严重影响了再生组织的形态和效果。天然高分子壳聚糖具有广谱抗菌、强效止血作用,无毒性降解物,具有良好的生物相容性、生物活性和生物可降解性良好,能够有效地促进创面愈合和组织修复再生,在生物医用敷料领域具有广阔的应用前景。本文主要综述近年来壳聚糖基创伤敷料设计成型方法,并讨论不同的成型工艺及负载不同抗菌剂的敷料性能及用途差异。以期能够为设计和开发新型壳聚糖基抗菌型创伤敷料材料提供重要参考。     

温敏性抗菌水凝胶的制备与控释技术研究进展

温敏水凝胶是一类通过感知温度变化使自身发生相变的智能型聚合物凝胶,通过负载抗菌剂或抗菌性单体制备抗菌水凝胶是近年来药物控制释放、组织工程以及生物免疫等领域关注的热点。本文概述了负载抗菌剂型温敏性抗菌水凝胶的物理交联和化学交联制备技术的研究概况,着重阐述了温敏性抗菌水凝胶的孔径调控、制备材料调控、载药模式调控等技术的研究进展,并对温敏性抗菌水凝胶的控释技术应用前景,特别是在生物质材料领域的应用前景进行了展望。     

自由基引发的可注射PLA-b-PEG-b-PLA大分子单体和α-CD超分子结构水凝胶的合成与表征

以数均分子量为6000的聚乙二醇为引发剂,以辛酸亚锡为催化剂引发丙交酯开环,再用甲基丙烯酸酐进行封端生成大分子单体.然后将大分子单体和α-环糊精混合,分别用维生素C和硫酸亚铁与过硫酸铵组成的氧化还原引发剂引发聚合,得到了两种不同结构的超分子结构水凝胶.用1HNMR,FTIR,TGA和XRD等分析测试手段对大分子单体及形成的水凝胶进行了表征.流变仪测试结果表明,该水凝胶固化时间合适,并具有可注射性.     

Injectable Graphene Oxide/Graphene Composite Supramolecular Hydrogel for Delivery of Anti-Cancer Drugs

Injectable hydrogels have attracted a lot of attention in drug delivery, however, their capacity to deliver water-insoluble or hydrophobic anti-cancer drugs is limited. Here, we developed injectable graphene oxide/graphene composite supramolecular hydrogels to deliver anti-cancer drugs. Pluronic F-127 was used to stabilize graphene oxide (GO) and reduced graphene oxide (RGO) in solution, which was mixed with α-cyclodextrin (α-CD) solution to form hydrogels. Native hydrogel was used as control. GO or RGO slightly shortened gelation time. The storage and loss moduli of the hydrogels were tracked by dynamic force measurement. The storage modulus of GO or RGO composite hydrogels was larger than that of the native hydrogel. Hydrogels were unstable in solution and eroded gradually. GO or RGO in Pluronic F-127 solution could potentially improve the solubility of the water-insoluble anti-cancer drug camptothecin (CPT), especially with large drug-loaded CPT amount. Drug release behaviors from solutions and hydrogels were characterized. The nanocomponents (GO or RGO) were able to bind more drug molecules either for CPT or for doxorubicin hydrochloride (DXR) in solution. Therefore, GO or RGO composite hydrogel could potentially enable better controlled and gentler drug release (for both CPT and DXR) than native hydrogel.     

Chitosan-Based Hydrogels for Infected Wound Treatment

Wound infections slow down the healing process and lead to complications such as septicemia, osteomyelitis, and even death. Although traditional methods relying on antibiotics are effective in controlling infection, they have led to the emergence of antibiotic-resistant bacteria. Hydrogels with antimicrobial function become a viable option for reducing bacterial colonization and infection while also accelerating healing processes. Chitosan is extensively developed as antibacterial wound dressings due to its unique biochemical properties and inherent antibacterial activity. In this review, the recent research progress of chitosan-based hydrogels for infected wound treatment, including the fabrication methods, antibacterial mechanisms, antibacterial performance, wound healing efficacy, etc., is summarized. A concise assessment of current limitations and future trends is presented.